Increased EZH2 expression in prostate cancer is associated with metastatic recurrence following external beam radiotherapy
Background Enhancer of zeste 2 (EZH2) promotes prostate cancer progression. We hypothesized that increased EZH2 expression is associated with postradiotherapy metastatic disease recurrence, and may promote radioresistance. Methods EZH2 expression was investigated using immunohistochemistry in diagno...
Saved in:
| Published in: | The Prostate Vol. 79; no. 10; pp. 1079 - 1089 |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
United States
Wiley Subscription Services, Inc
01.07.2019
John Wiley and Sons Inc |
| Subjects: | |
| ISSN: | 0270-4137, 1097-0045, 1097-0045 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!